Protuoso Biosciences, a burgeoning US-based biotechnology company, has successfully closed a $9.5 million seed financing round, positioning itself to revolutionize…
Read More
Isomorphic Labs Secures $2.1 Billion in Series B Funding to Accelerate AI-Driven Drug Discovery and Development
AI drug design and development firm Isomorphic Labs has successfully closed a significant $2.1 billion Series B funding round, marking…
Read More
Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline
Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…
Read More
Cancer Scientists Unite at AACR Annual Meeting, Send Powerful Message to Congress on Sustained Research Funding
On Sunday morning at the San Diego Convention Center, every attendee seated in Hall H for the Opening Ceremony and…
Read More
Cancer Scientists Unanimously Advocate for Sustained Congressional Funding at AACR Annual Meeting in San Diego
On Sunday morning, at the bustling San Diego Convention Center, a powerful demonstration of unity and gratitude unfolded as attendees…
Read More
Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager Pipeline
Chinese biotech startup Excalipoint Therapeutics has officially launched with a substantial $68.7 million in seed funding, positioning itself to accelerate…
Read More
Vitestro Secures $70 Million Series B Funding to Revolutionize Blood Collection with Autonomous Robotics
Vitestro, a pioneering Dutch medical technology firm, has successfully closed an oversubscribed Series B financing round, securing an impressive $70…
Read More
Parkinson’s Disease Research Reaches Pivotal Point Amidst Funding and Trial Hurdles
The scientific understanding of Parkinson’s disease (PD) has advanced significantly, placing preclinical and clinical research at a critical juncture. However,…
Read MoreYOU MAY HAVE MISSED
